Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 16, 2014
Joint Health Supplement Contains Dangerous Drugs, FDA Warns
Diclofenac, ibuprofen, naproxen, and indomethacin are non-steroid anti-inflammatory drugs (NSAIDs), which can increase the risk of cardiovascular events and gastrointestinal damage, such as bleeding, ulceration, and fatal perforation of the stomach.
Chlorzoxazone is a prescription muscle relaxant which can cause drowsiness and dizziness, and may interfere with the ability to perform certain tasks such as driving or operating machinery.
Nefopam is non-narcotic pain relief drug that is not FDA-approved for marketing in the U.S. Rapid heart rate, sweating, dizziness, confusion, hallucinations, and seizures have been reported with the use of this drug.
Pro ArthMax is sold in some retail stores and on various websites, including www.nanowellusa.com. It is also promoted to the Korean-speaking community (use the link below to the FDA's warning letter, which includes the Korean translation of Pro ArthMax's name).
It is labeled as containing methyl sulfonyl methane (MSM), Chinese boxthorn, Astragalus membranaceus, Cuscuta chinensis limak and Astracytlodes macrocephala.
Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects, including unusually dark stools or urine, stomach pain, increased bruising, other signs of bleeding, confusion, sedation, hallucinations, and seizures. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Joint Health Supplements for tests of related products.
See Related Warnings:
To read the FDA's warning, use the link below.